Ignite Creation Date:
2024-07-17 @ 11:05 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483347
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-23
Brief Title:
Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Organization Data
Organization:
Second Affiliated Hospital of Guangzhou Medical University
Class:
OTHER
Study ID:
ZZ-IT-ICI-LC 1line-025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None